RecruitingNot ApplicableNCT07092020

Extended Depth of Focus (EDF) Intraocular Lens (IOL) Versus Monofocal Intracoular Lens (IOL)

A Prospective, Randomized, Controlled, Observer-masked, Multi-center Clinical Trial to Demonstrate the Safety and Effectiveness of the Extended Depth of Focus AT LARA 829MP Posterior Chamber Intraocular Lens for Correction of Aphakia


Sponsor

Carl Zeiss Meditec AG

Enrollment

220 participants

Start Date

Oct 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Extended depth of focus (EDF) intraocular lens (IOL) versus Monofocal intraocular lens (IOL)


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called EDF and a medical device called Monofocal IOL for people with cataract senile. The study is currently recruiting participants at 14 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEEDF

Extended depth of focus

DEVICEMonofocal IOL

Monofocal


Locations(14)

Eye Hospital Zora

Sofia, Bulgaria

Specialized Ophthalmological Hospital for Active Treatment

Sofia, Bulgaria

Medical Center "Vereya"

Stara Zagora, Bulgaria

Nemocnice Havlíčkův

Havlíčkův Brod, Czechia

OFTEX ocni

Pardubice, Czechia

Oční Centrum

Prague, Czechia

Oculus Eye Clinic

Bucharest, Romania

Ofta Total Clinic

Sibiu, Romania

Medoptic Clinic

Suceava, Romania

Oftalvist

Alicante, Spain

Hospital Universitario Ramón y Cajal

Madrid, Spain

OMIQ Hospital Universitari

Sant Cugat del Vallès, Spain

University Hopital Complex of Santiago de Compostela

Santiago de Compostela, Spain

Oftalvist

Valencia, Spain

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07092020